transformation product analysis: ready to go beyond ... · comprehensive enumeration of tps,...

34
Transformation product analysis: Ready to go beyond suspect screening? Kathrin Fenner , Rebekka Gulde, Juliane Hollender, Jennifer Schollée, Heinz Singer

Upload: others

Post on 15-Feb-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Transformation product analysis: Ready to go beyond suspect screening?

Kathrin Fenner, Rebekka Gulde, Juliane Hollender, Jennifer Schollée, Heinz Singer

Page 2: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Thoughts of a chemist parent

Similar looks

Behavior

At the playground

ON

N

N

HNN

N

In the lab

Reaction

Similar looks

Behavior

Reaction

Page 3: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

TP search with high-resolution MS Overview of strategies

Rel

atio

nshi

p

Context

Reaction

Known parent Unknown parent Experiment Field samples Field samples

Suspect screening & mass defect filtering

Multiple observations

Single sample

Multiple observations

MS1

MS2/ MSn

Trend

Structural similarity

Page 4: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Prioritization

Confirmation

m/z extracted ion chromatogram

Generation of suspect list

Suspect screening Looking for expected transformation products

Parents of interest

Structural interpretation

Environmental relevance, chemical classes

Batch studies, literature, prediction systems, library of transformations

HR-MS full scan of sample(s)

Isotope fit, plausible retention time, absence in blank, ionization behavior

Expected trend, intensity

Data-dependent MS/MS, interpretation of fragmentation patterns

Page 5: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Suspect screening Transformation products in natural waters

52 highly used biocides, pesticides and pharmaceuticals

1794 possible transformation products from literature and Eawag-PPS

HR-MS full scan of sample(s)

Isotope fit, plausible retention time, absence in blank, ionization behavior

Expected trend, intensity

Data-dependent MS/MS, interpretation of fragmentation patterns Kern et al., 2008, ES&T

Prioritization

Confirmation

m/z extracted ion chromatogram

Generation of suspect list

Parents of interest

Structural interpretation

Page 6: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

•  Artificial intelligence system to predict likely microbial transformation pathways

•  About 250 biotransformation rules applied •  Batch mode available upon request

Eawag-PPS

BBD Home > PPS Home > 1 [Zoom In][Zoom Out][Print Size][Clear][?]

UM-BBD: Pathway Prediction Results

[About] [Tips] [Not Predicted] [All Rules]

The predicted pathway:

Aerobic Likelihood:

Very likely Likely Neutral

Prediction Options:

Show Biotransformations:

www.eawag-bbd.ethz.ch/predict envipath.org

Prediction of microbial biotransformation

Page 7: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Suspect screening Transformation products in natural waters

1057 peaks found in at least on of 7 water samples

957 without blank peaks 640 peaks intensity ≥105

438 reasonable retention time 415 peaks with correct isotope pattern 371 peaks with correct ionization mode

Data-dependent MS/MS, interpretation of fragmentation patterns

52 highly used biocides, pesticides and pharmaceuticals

1794 possible transformation products from literature and Eawag-PPS

Kern et al., 2008, ES&T

Prioritization

Confirmation

m/z extracted ion chromatogram

Generation of suspect list

Parents of interest

Structural interpretation

Page 8: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Retention time filter

Reversed phase X-Bridge, MeOH-water gradient

Crude, realistic, but still efficient

Kern et al., 2008, ES&T

Page 9: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Suspect screening Transformation products in natural waters

1057 peaks found in at least on of 7 water samples

957 without blank peaks 640 peaks intensity ≥105

438 reasonable retention time 415 peaks with correct isotope pattern 371 peaks with correct ionization mode

19 proposed structures

52 highly used biocides, pesticides and pharmaceuticals

1794 possible transformation products from literature and Eawag-PPS

O

N N

O

N

O

OH

OH3C

NH

NN

O CH3

Metamitron-desamino

Azoxystrobin acid

N

O

O

H2N

OH3C

HN

CH3OH

N-desmethyl venlafaxin

Carbamazepine-10,11-epoxide ...

OH3C

OCH3

NH3C

CH3HN

CH3

O

OH

O

OH

NHH3C

CH3

Atenolol acid

D617 (Verapamil TP)

...

Prioritization

Confirmation

m/z extracted ion chromatogram

Generation of suspect list

Parents of interest

Structural interpretation

Page 10: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Suspect screening & case-control Transformation products along river

54 after blank subtraction, intensity filter, and isotope pattern check 19 with increasing trends (Attx < 0) 8 after retention time filter (ΔlogKow vs ΔRT) and ionization plausibility check

8 proposed structures

32 organic micropollutants (out of 2560) with decreasing trends along 4 river stretches

1315 possible transformation products from Eawag-PPS (3 generations)

Li et al., 2016, manuscript in preparation

Prioritization

Confirmation

m/z extracted ion chromatogram

Generation of suspect list

Parents of interest

Structural interpretation

Page 11: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

TP search with high-resolution MS Overview of strategies

Rel

atio

nshi

p

Context

Reaction

Known parent Unknown parent Experiment Field samples Field samples

Suspect screening & mass defect filtering

Multiple observations

Single sample

Multiple observations

Trend

Structural similarity

Page 12: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

A few words on mass defect filtering “Extended suspect screening”, example nefazodone

Zhang et al., 2009, J. Mass. Spectrom.

: First generation suspects B, C and D

40 mD

a

50 Da

Page 13: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

TP search with high-resolution MS Overview of strategies

Rel

atio

nshi

p

Context

Reaction

Known parent Unknown parent Experiment Field samples Field samples

Suspect screening & mass defect filtering

Multiple observations

Single sample

Multiple observations

Trend

Structural similarity

Trend or case-control filtering

Page 14: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Trend screening in spike experiments Comprehensive enumeration of TPs, pathway elucidation

Helbling et al., 2010, ES&T Gulde et al., 2016, ES&T

Extracted ion chromatogram (XIC)

HR-MS full scan of sample(s), automated peak detection, blank subtraction

Further prioritization Componentization; reasonable molecular formula , m/z and RT relative to parent compound

Structural interpretation

Trend filter Increasing or increasing/decreasing trend, absence in matrix controls

t=0 1h 2h 4h 8h 1d 2d

Sample time series t=0 1h 2h 4h 8h 1d 2d

A3 A2 A1 A6 A5 A4 A7

Page 15: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Pargyline

ortho-chlorophenyl

piperazine

Pheniramine Pyrilamine

Primaquine

Venlafaxine

Mexiletine

N-demethyl venlafaxine

Chlorcyclizine

Deprenyl

N-demethyl pheniramine

Lidocaine Spiroxamine N,N-dimethyl

-p-chloroanilin

Fenfluramine

1[(4-chlorophenyl) phenylmethyl]

piperazine

Norfluoxetine

Fluoxetine

Clenisopenterol

Trend screening in spike experiments

Gulde et al., 2016, ES&T

Comprehensive enumeration of amine transformation pathways

Page 16: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Sample time series

Trend screening in spike experiments Comprehensive enumeration of TPs, pathway elucidation

Helbling et al., 2010, ES&T Gulde et al., 2016, ES&T

Extracted ion chromatogram (XIC)

Trend filter Prioritized suspect list

Structural interpretation

Triplicates of 19 bioreactors spiked with separate compounds, 9 time points per compound/reactor

144 peaks (or components) with expected trend and plausible molecular formula

Further prioritization

Page 17: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Trend screening in spike experiments Exemplary results for pyrilamine

Gulde et al., 2016, ES&T

Page 18: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Pyrilamine (parent):

Prediction of sum formula based on likely atoms; consistent isotopic pattern à Molecular formula: C16H21N3O Level 4

Difference to parent compound: à  -CH2

Demethylation at ether or tertiary amine group Level 3

MS spectrum

Data for TP: Confidence levels:

Structure elucidation Communicating confidence

Level  1:    Confirmed    structure    by  reference  standard  

Level  2:    Probable  structure                                a)  by  library  spectrum  match                                b)  by  diagnos6c  evidence  

Level  3:  Tenta9ve  candidate(s)    structure,  subs6tuent,  class  

Level  4:    Unequivocal  molecular  formula  

Level  5:  Exact  mass  of  interest  

Schymanski et al., 2014, ES&T

Page 19: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

19

Marked fragments provide diagnostic evidence for demethylation at the ether group

à Structure identifiable with high confidence Level 2b

m/z

Inte

nsity

[cou

nts]

(10^

3)

Pyrilamine (parent):

Confidence levels:

Structure elucidation Communicating confidence

Level  1:    Confirmed    structure    by  reference  standard  

Level  2:    Probable  structure                                a)  by  library  spectrum  match                                b)  by  diagnos6c  evidence  

Level  3:  Tenta9ve  candidate(s)    structure,  subs6tuent,  class  

Level  4:    Unequivocal  molecular  formula  

Level  5:  Exact  mass  of  interest  

Schymanski et al., 2014, ES&T

MS2 spectrum

Data for TP:

Page 20: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Trend screening in spike experiments Exemplary results for pyrilamine

Gulde et al., 2016, ES&T

(…) I applaud the authors for making all of their hard and

meticulous work available to the ES&T readers. The transparency

and clarity in this submission is refreshing, and something that most

contributors to ES&T should aspire to.

Page 21: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Amine biotransformation pathways Multiple, but consistent transformations across 19 amines

Gulde et al., 2016, ES&T

Page 22: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

TP search with high-resolution MS Overview of strategies

Rel

atio

nshi

p

Context

Reaction

Known parent Unknown parent Experiment Field samples Field samples

Suspect screening & mass defect filtering

Multiple observations

Single sample

Multiple observations

Trend

Structural similarity

Trend or case-control filtering

Trend or case-control filtering

Page 23: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Trend screening in process studies Characterization of processes, removal/formation of micropollutants

Getzinger et al., 2016, personal communication

Page 24: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

TP search with high-resolution MS Overview of strategies

Rel

atio

nshi

p

Context

Reaction

Known parent Unknown parent Experiment Field samples Field samples

Suspect screening & mass defect filtering

Multiple observations

Single sample

Multiple observations

Trend

Structural similarity

Trend or case-control filtering

Trend or case-control filtering

Reaction screening

Page 25: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Principal  Component  Analysis  R  ‘prcomp’package  Characteris6c  peaks  extracted  

Linkage  for  parent/TP  pairs  Difference  analysis  from  known  biotransforma6ons  

Priori8za8on  of  links  for  targeted  MS/MS  Used  peak  shape,  peak  intensity,  and  significance  of  intensity  difference  

Further  links  priori8za8on  ‘OrgMassSpecR’    /  ‘RMassBank’    packages  Similarity  of  MS/MS  spectra  in  each  link  

Schollée et al., 2016, Anal. Chem.

Environmental chemistry: Finding PC-TP pairs in EICs from process samples (ozonation, WWTP)

Reaction screening Process evaluation, finding unknown parent-TP pairs

Morreel et al., 2014, Plant Cell

Systems biology: Structural Characterization of Metabolites in Arabidopsis via Candidate Substrate-Product Pair Networks

Reaction

Trend

Chemical similarity

Page 26: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

MSMS similarity as PC-TP pair filter

Schollée et al., 2016, submitted to Anal. Chem.

Page 27: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

TP search with high-resolution MS Overview of strategies

Rel

atio

nshi

p

Context

Reaction

Known parent Unknown parent Experiment Field samples Field samples

Suspect screening & mass defect filtering

Multiple observations

Single sample

Multiple observations

Trend

Structural similarity

Trend or case-control filtering

Trend or case-control filtering

Reaction screening

Fragment or fragmentation screening (neutral loss, common fragment etc.)

Page 28: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Parent(s) of interest

XIC from HR-MS

Environmental samples(s)

Fragment screening Comprehensive enumeration of TPs, pathway elucidation

Known or predicted MS/MS spectra

Mistrik et al., 2010, Drug Metabol. Rev.

XIC from (HR)-MSMS Fragment filter

RT search template

Further prioritization

Structural interpretation

Parent(s) of interest

Page 29: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

Fragment screening Comprehensive enumeration of TPs, pathway elucidation

5 pharmaceuticals with high production volume and significant removal in WWTP

Boix et al., 2016, J. Hazard. Mat. Other example: Zonja et al., 2016, ES&T

3-4 known fragment ions of parent and/or known TP

New RT of interest for venlafaxine

New parent ion mass at that RT

XIC from HR-MS

WWTP & SW samples(s)

XIC from (HR)-MSMS Fragment filter Parent(s) of

interest

RT search template

Further prioritization

Structural interpretation

Page 30: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

TP search with high-resolution MS Conclusions

Rel

atio

nshi

p

Context

Reaction

Known parent Unknown parent Experiment Field samples Field samples

Multiple observations

Single sample

Multiple observations

Trend

Structural similarity

Reaction screening

Suspect screening & mass defect filtering

Trend or case-control filtering

Trend or case-control filtering

Fragment or fragmentation screening (neutral loss, common fragment etc.)

Fragment or fragmentation screening (neutral loss, common fragment, MSMS similarity etc.)

Page 31: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

New biotransformation database & prediction tool enviPath (https://envipath.org, former Eawag-BBD)

•  Public and private data •  Easy data entry and metadata

annotation •  Biotransformation rules for

pathway prediction •  Relative reasoning models •  Machine-learning methods for

training own models

•  Central resource for contaminant biotransformation pathways

•  Database and pathway prediction

Wicker et al., Nucleic Acids Res., 44, 2016

Page 32: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

The road ahead…

•  Data-independent or all ion fragmentation experiments •  Data processing workflows to sort together fragment ion

and parent ion peaks

•  Efficient data processing software solutions

•  Complementary chromatographic methods to capture polar and ionic TPs

Page 33: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal

PhD students: Michele Stravs Technicians: Philipp Longrée Postdocs: Damian Helbling Martin Loos Funding:

Thanks…

Page 34: Transformation product analysis: Ready to go beyond ... · Comprehensive enumeration of TPs, pathway elucidation 5 pharmaceuticals with high production volume and significant removal